ESC Premium Access

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? Positioning of the topic

Presentation

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)
28 presentations
1 follower

4 more presentations in this session

All we need are antiplatelet agents – PRO

Speaker: Doctor A. Colombo (Milan, IT)

Thumbnail

All we need are antiplatelet agents – CON

Speaker: Professor L. Soendergaard (Copenhagen, DK)

Thumbnail

All we need are antiplatelet agents – Discussion PRO/CONTRA.

Thumbnail

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants? - Conclusion

Speaker: Professor S. Windecker (Bern, CH)

Thumbnail

Access the full session

Thromboembolic prevention after TAVI: antiplatelets or anticoagulants?

Speakers: Professor R. Mehran, Doctor A. Colombo, Professor L. Soendergaard, Professor S. Windecker
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk